- Home
- BME vs LAB Comparison
BME vs LAB Comparison
Compare BME & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- LAB
- Stock Information
- Founded
- BME 2005
- LAB 1999
- Country
- BME United States
- LAB United States
- Employees
- BME N/A
- LAB N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- BME Finance
- LAB Industrials
- Exchange
- BME Nasdaq
- LAB Nasdaq
- Market Cap
- BME 525.3M
- LAB 562.1M
- IPO Year
- BME N/A
- LAB 2011
- Fundamental
- Price
- BME $38.13
- LAB $2.21
- Analyst Decision
- BME
- LAB Strong Buy
- Analyst Count
- BME 0
- LAB 2
- Target Price
- BME N/A
- LAB $2.88
- AVG Volume (30 Days)
- BME 34.0K
- LAB 1.6M
- Earning Date
- BME 01-01-0001
- LAB 10-30-2024
- Dividend Yield
- BME 6.26%
- LAB N/A
- EPS Growth
- BME N/A
- LAB N/A
- EPS
- BME 1.44
- LAB N/A
- Revenue
- BME N/A
- LAB $155,902,000.00
- Revenue This Year
- BME N/A
- LAB $62.60
- Revenue Next Year
- BME N/A
- LAB $9.91
- P/E Ratio
- BME $28.37
- LAB N/A
- Revenue Growth
- BME N/A
- LAB 48.23
- 52 Week Low
- BME $35.53
- LAB $1.21
- 52 Week High
- BME $43.20
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- BME 29.90
- LAB 65.48
- Support Level
- BME $38.00
- LAB $1.82
- Resistance Level
- BME $39.24
- LAB $2.07
- Average True Range (ATR)
- BME 0.36
- LAB 0.15
- MACD
- BME -0.09
- LAB 0.04
- Stochastic Oscillator
- BME 6.97
- LAB 92.45
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.